Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

Report Summary

GBI Research’s report, “Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape” provides detailed insight into the American API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the American API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The API Market revenues in the Americas are expected to grow at a Compounded Annual Growth Rate (CAGR) of 4.7% from 2010 to 2015. As the North American pharmaceutical market recovers from the impacts of economic downturn, the API market revenues are expected to witness a steady growth. The faster growing markets of South and Central America will have greater contribution to the overall Americas API market growth. Brazil, especially, is witnessing very strong growth in pharmaceuticals and API market revenues and is expected to overtake Mexico in the coming years.

Scope

• Market revenue data for APIs from 2005 to 2010 and forecast for six years to 2016
• API markets in key countries in the region: the US, Canada, Mexico and Brazil
• API industry structure and market trends such as shift of market from branded to generic and rise of biotechnology in the American region
• Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and SWOT analysis of the API market for the region’s key countries
• Information on the competitive landscape, with shares of leading companies such as Pfizer Inc., Astrazeneca International, GlaxoSmithKline Pharmaceuticals Ltd., Roche and Sanofi Aventis
• Analysis of API revenue based on product types in the American market and in key countries of the region.
• Analysis of API revenue based on therapeutic categories in the key countries.

Reasons to buy

• Develop business strategies with the help of specific insights on the American API market.
• Identify opportunities and challenges in the American API market.
• Invest in the growing segments of the API market.
• Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the American API market.
• Benchmark your operations and strategies against the major players in the global API market.

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION
2.1 GBI Report Coverage

3 AMERICAS API MARKET
3.1 Americas API Industry Structure
3.2 Americas API Industry Challenges
3.2.1 Economic Downturn has Restricted Investment in Pharmaceutical Industry
3.2.2 High Costs Hinder New Drug Development in the Region
3.2.3 Maturity of Synthetic APIs Hamper Profit Margin Growth
3.2.4 Regulatory Changes Lead to Delays in the Launch of New Drugs in the Market
3.2.5 Patent Expiries of Best Selling Drugs Threatens Revenue Growth
3.3 Americas API Industry Trends
3.3.1 Patent Expiries are Changing Pharmaceutical Market Dynamics in America
3.3.2 Specialty Driven Products are Expected to Play an Important Role in the American API Market
3.3.3 Outsourcing of API Manufacturing is Growing Fast in America
3.3.4 Mergers and Acquisitions (M&A) Activities have Increased Significantly in the American Pharmaceutical Industry
3.4 Americas API Market Revenue Analysis and Forecasts to 2016
3.5 Americas API Market Revenue Share Analysis by Product Type and Forecasts to 2016
3.5.1 Americas API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016
3.5.2 Americas API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016
3.6 Americas API Market Revenue Share Analysis by Country and Forecasts to 2016
3.7 North America API Market
3.7.1 North America API Market Overview
3.7.2 North America API Market Drivers
3.7.3 North America API Market Restraints
3.7.4 North America API Market Revenue Analysis and Forecasts to 2016
3.7.5 North America API Market Revenue Share Analysis by Product Type and Forecasts to 2016
3.7.6 North America API Market Revenue Share Analysis by Country and Forecasts to 2016
3.8 North America API Market Competitive Landscape
3.9 South and Central America API Market
3.9.1 South and Central America API Market Overview
3.9.2 South and Central America API Market Drivers
3.9.3 South and Central America API Market Restraints
3.9.4 South and Central America API Market Revenue Analysis and Forecasts to 2016
3.9.5 South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2016
3.9.6 South and Central America API Market Revenue Share Analysis by Country and Forecasts to 2016
3.9.7 South and Central America API Market Competitive Landscape

4 THE US API MARKET
4.1 The US API Market Overview
4.2 The US API Market Drivers
4.2.1 The Rising Incidence of Lifestyle and Old Age Diseases is Giving Rise to API Demand in the Region
4.2.2 Growth in Oncology is One of the Major Contributing Factors to the Growth of APIs in the Region
4.2.3 Growth in Biotechnology will Favor Growth of API Market Revenues
4.2.4 Increasing Focus on High Potency APIs Helps Market Growth
4.3 The US API Market Restraints
4.3.1 The Economic Downturn has Restricted the Growth of API Demand in the US
4.3.2 Decreasing Focus on the Innovator Sector Limits the Growth of the US API Market
4.3.3 Patent Expiry of Some Blockbuster Molecules Will Adversely Affect the Growth of the API Market in the Region
4.3.4 Rising Competition from China and India is Creating Price Pressure in the US Market
4.4 The US API Market Revenue Analysis and Forecasts to 2015
4.5 The US API Market Revenue Share Analysis by Product Type and Forecasts to 2015
4.5.1 The US API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015
4.5.2 The US API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
4.6 The US API Market Revenue Share Analysis by Therapeutic Category
4.7 The US API Market SWOT Analysis
4.7.1 Strengths
4.7.2 Weaknesses
4.7.3 Opportunities
4.7.4 Threats

5 CANADA API MARKET
5.1 Canada API Market Overview
5.2 Canada API Market Drivers
5.2.1 Government Support for Increasing Healthcare Standards Encourages API Market Growth
5.2.2 Fast Growing Biotechnology Industry in the Country Increases Demand for APIs
5.2.3 Growth in Old Age Population in Canada Provides Leads to Growth of the API Market
5.3 Canada API Market Restraints
5.3.1 Patent Expiries of Some Blockbuster Drugs Will Negatively Impact the API Market
5.3.2 Price Controls by the Government Affects API Market Revenues
5.4 Canada API Market Revenue Analysis and Forecasts to 2015
5.5 Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2015
5.5.1 Canada API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015
5.5.2 Canada API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
5.6 Canada API Market Revenue Share Analysis by Therapeutic Category
5.7 Canada API Market SWOT Analysis
5.7.1 Strengths
5.7.2 Weaknesses
5.7.3 Opportunities
5.7.4 Threats

6 MEXICO API MARKET
6.1 Mexico API Market Overview
6.2 Mexico API Market Drivers
6.2.1 Strong Growth in Pharmaceutical Market Leads the API Market in Mexico
6.2.2 Rapid Growth in Generics Market Encouraging API Demand
6.3 Mexico API Market Restraints
6.3.1 Patent Expiries of Blockbuster Drugs will Negatively Impact Market Revenue Growth
6.3.2 The Problem of Counterfeits Challenging the Market
6.4 Mexico API Market Revenue Analysis and Forecasts to 2015
6.5 Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2015
6.5.1 Mexico API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015
6.5.2 Mexico API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
6.6 Mexico API Market Revenue Share Analysis by Therapeutic Category
6.7 Mexico API Market SWOT Analysis
6.7.1 Strengths
6.7.2 Weaknesses
6.7.3 Opportunities
6.7.4 Threats

7 BRAZIL API MARKET
7.1 Brazil API Market Overview
7.2 Brazil API Market Drivers
7.2.1 Strongly Growing Economy Gives Boost to the API Market
7.2.2 Increase in Old Age Population Gives Rise to APIs Demand
7.2.3 Rapidly Growing Demand for Generic Drugs will Drive the Country’s API Market
7.3 Brazil API Market Restraints
7.3.1 Delay in Drug Approvals Hinders the Market Growth
7.3.2 The Dependency on Imports for Pharmaceutical Raw Materials Restricts Market Growth
7.4 Brazil API Market Revenue Analysis and Forecasts to 2015
7.5 Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2015
7.5.1 Brazil API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015
7.5.2 Brazil API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015
7.6 Brazil API Market Revenue Share Analysis by Therapeutic Category
7.7 Brazil API Market SWOT Analysis
7.7.1 Strengths
7.7.2 Weaknesses
7.7.3 Opportunities
7.7.4 Threats

8 APPENDIX
8.1 Abbreviations
8.2 Methodology
8.2.1 Coverage
8.2.2 Secondary Research
8.2.3 Primary Research
8.2.4 Expert Panel Validation
8.3 Contact Us
8.4 About GBI Research
8.5 Disclaimer 92

LIST OF TABLES

Table 1: API Market, Americas, Revenues, $m, 2005-2016
Table 2: API Market, Americas, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Table 3: API Market, Americas, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Table 4: API Market, Americas, Revenue Share by Country, %, 2010 and 2016
Table 5: API Market, North America, Major Drugs to Lose Patent Protection, 2011 and 2012
Table 6: API Market, North America, Revenues, $m, 2005-2016
Table 7: API Market, North America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Table 8: API Market, North America, Revenue by Product Type Based on Synthesis Route, $m, 2005- 2016
Table 9: API Market, North America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Table 10: API Market, North America, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Table 11: API Market, North America, Revenue Share by Country, %, 2010 and 2016
Table 12: API Market, North America, Competitive Landscape, %, 2010
Table 13: API Market, South and Central America, Revenues, $m, 2005-2016
Table 14: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Table 15: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016
Table 16: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Table 17: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Table 18: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016
Table 19: API Market, The US, Revenues, $m, 2005-2016
Table 20: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Table 21: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016
Table 22: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Table 23: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Table 24: API Market, The US, Revenue Share by Therapeutic Category, %, 2010
Table 25: API Market, Canada, Revenues, $m, 2005-2016
Table 26: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Table 27: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016
Table 28: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Table 29: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Table 30: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010
Table 31: API Market, Mexico, Revenues, $m, 2005-2016
Table 32: API Market, Mexico, Revenue Share by Product Types Based on Synthesis Route, %, 2010 and 2016
Table 33: API Market, Mexico, Revenues by Product Types Based on Synthesis Route, $m, 2005-2016
Table 34: API Market, Mexico, Revenue Share by Product Types Based on Customer Base, %, 2010 and 2016
Table 35: API Market, Mexico, Revenue by Product Types Based on Customer Base, $m, 2005-2016
Table 36: API Market, Mexico, Revenue Share by Therapeutic Category, %, 2010
Table 37: API Market, Brazil, Revenues, $m, 2005-2016
Table 38: API Market, Brazil, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Table 39: API Market, Brazil, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016
Table 40: API Market, Brazil, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Table 41: API Market, Brazil, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Table 42: API Market, Brazil, Revenue Share by Therapeutic Category, %, 2010 87

LIST OF FIGURES

Figure 1: API, Global, Industry Value Chain, 2010
Figure 2: API Market, Americas, Revenues, $m, 2005-2016
Figure 3: API Market, Americas, Product Type, 2010
Figure 4: API Market, Americas, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Figure 5: API Market, Americas, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Figure 6: API Market, Americas, Revenue Share by Country, %, 2010 and 2016
Figure 7: API Market, North America, Revenues, $m, 2005-2016
Figure 8: API Market, North America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Figure 9: API Market, North America, Revenue by Product Type Based on Synthesis Route, $m, 2005- 2016
Figure 10: API Market, North America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Figure 11: API Market, North America, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Figure 12: API Market, North America, Revenue Share by Country, %, 2010 and 2016
Figure 13: API Market, North America, Competitive Landscape, %, 2010
Figure 14: API Market, South and Central America, Revenues, $m, 2005-2016
Figure 15: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Figure 16: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016
Figure 17: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Figure 18: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Figure 19: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016
Figure 20: API Market, The US, Revenues, $m, 2005-2016
Figure 21: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Figure 22: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016
Figure 23: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Figure 24: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Figure 25: API Market, The US, Revenue Share by Therapeutic Category, %, 2010
Figure 26: API Market, The US, SWOT, 2010
Figure 27: API Market, Canada, Revenues, $m, 2005-2016
Figure 28: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Figure 29: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016
Figure 30: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Figure 31: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Figure 32: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010
Figure 33: API Market, Canada, SWOT, 2010
Figure 34: API Market, Mexico, Revenues, $m, 2005-2016
Figure 35: API Market, Mexico, Revenue Share by Product Types Based on Synthesis Route, %, 2010 and 2016
Figure 36: API Market, Mexico, Revenues by Product Types Based on Synthesis Route, $m, 2005-2016
Figure 37: API Market, Mexico, Revenue Share by Product Types Based on Customer Base, %, 2010 and 2016
Figure 38: API Market, Mexico, Revenue by Product Types Based on Customer Base, $m, 2005-2016
Figure 39: API Market, Mexico, Revenue Share by Therapeutic Category, %, 2010
Figure 40: API Market, Mexico, SWOT Analysis, 2010
Figure 41: API Market, Brazil, Revenues, $m, 2005-2016
Figure 42: API Market, Brazil, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016
Figure 43: API Market, Brazil, Revenues by Product Type Based on Synthesis Route, $m, 2005-2016
Figure 44: API Market, Brazil, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016
Figure 45: API Market, Brazil, Revenue by Product Type Based on Customer Base, $m, 2005-2016
Figure 46: API Market, Brazil, Revenue Share by Therapeutic Category, %, 2010
Figure 47: API Market, Brazil, SWOT Analysis, 2010 88